Archives

by in
Entry Author Date Location
Enanta Pockets $75M As AbbVie, Gilead Hep C Battle Begins 12/19/14 Boston
“Innovation at Biotech’s Epicenter,” Dec. 17: Check Out the Agenda 12/10/14 San Francisco
Prescription Drug Pricing: The Fine Line Between Value and Greed 12/02/14 Boston
West Coast Biotech Roundup: Gilead, Juno, Hutch, Fibrogen & More 11/20/14 Seattle
With Gilead’s $125M Purchase, FDA Voucher Program Gains Momentum 11/19/14 San Francisco
East Coast Biotech Roundup: Regeneron, Sage, Tara, Alnylam, & More 11/14/14 Boston
East Coast Biotech Roundup: Intercept, Idera, Inotek, & More 11/07/14 Boston
Chimerix Plans $105M Stock Offering to Finance Ebola Drug Trials 10/30/14 Raleigh Durham
Chimerix Antiviral to Start in Ebola Clinical Trial 10/16/14 Raleigh Durham
What Seattle Needs (Part 3): Working Together to Revitalize Biotech 10/08/14 Seattle
Texas Ebola Patient Gets Chimerix Drug, Clinical Trials Planned 10/06/14 Raleigh Durham
Austin Biotech Savara Nets $10M to Develop Cystic Fibrosis Drug 10/06/14 Texas
What Seattle Needs (Part 1): “Semi-Successful” Biotech Companies 10/06/14 Seattle
Alios’s Corporate Venture Backers Ride RSV (And Hep C) To Big Payday 10/01/14 San Francisco
West Coast Biotech Roundup: Ebola, Immunotherapy, Avalon & More 09/26/14 San Francisco
West Coast Biotech Roundup: Halozyme, Nektar, Allozyne, Novo & More 09/18/14 Seattle
AbbVie Plunks Down $275M Upfront for Infinity’s Blood Cancer Drug 09/03/14 Boston
Coelacanths And Other IPO Thoughts Before The Autumn Markets Return 08/26/14 National
East Coast Biotech Roundup: Amicus, Accelerator, Seventh Sense, & More 08/15/14 Boston
To Take On New York, Accelerator Makes Big Changes 08/14/14 New York
West Coast Biotech Roundup: Amgen Layoffs, Avalanche, Venter & More 07/31/14 Seattle
West Coast Biotech Roundup: IPOs, Gilead, Sofinnova, & Denouements 07/25/14 San Diego
BioCryst Bets on New Ebola Drug to Fight Bioterror, Outbreak Threats 07/24/14 Raleigh Durham
Gilead Edges Into Cancer Field With FDA OK of Calistoga Drug 07/23/14 San Francisco
Who Needs Biotech VCs, Anyway? 07/15/14 San Francisco
West Coast Biotech Roundup: Scripps, Trounson, Versant, Gilead, & More 07/10/14 San Francisco
King of BIO: The Chairwoman of Biotech’s Top Trade Org Talks Policy 06/25/14 San Diego
SF Biotech Venture Vet Steve Burrill Dumped by LPs, Sued for Fraud 06/18/14 San Francisco
Merck Scoops Up Idenix in $3.85B Buyout 06/09/14 Boston
Akebia, Trading M&A For an IPO, Follows Fast in Anemia Drug Race 06/09/14 Boston
Page 1 of 7 next page »